Search Results - Xintian Wang

Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US by Yingcheng Wang, Yingcheng Wang, Mingjun Rui, Mingjun Rui, Lan Yang, Lan Yang, Xintian Wang, Xintian Wang, Ye Shang, Ye Shang, Aixia Ma, Aixia Ma, Hongchao Li, Hongchao Li

Connect to this object online.

Protective Role of L-3-n-Butylphthalide in Cognitive Function and Dysthymic Disorders in Mouse With Chronic Epilepsy by Xiaowen Ye, Xiaowen Ye, Zhouyi Rong, Yanfang Li, Xintian Wang, Xintian Wang, Xintian Wang, Baoying Cheng, Yiyun Cheng, Yiyun Cheng, Yiyun Cheng, Haijuan Luo, Haijuan Luo, Yue Ti, Xiaohua Huang, Zhaoji Liu, Zhaoji Liu, Yun-wu Zhang, Weihong Zheng, Weihong Zheng, Weihong Zheng, Honghua Zheng, Honghua Zheng, Honghua Zheng

Connect to this object online.

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma by Ting Zhou, Xintian Wang, Yingdan Cao, Lan Yang, Zijing Wang, Aixia Ma, Hongchao Li

Connect to this object online.

Development and preliminary validation of a public health emergency competency model for medical staffs of national health emergency teams in China by Yuhan Zhao, Yuanyuan Wang, Ting Zhang, Miaomiao Wang, Xiaojun Ye, Xintian Wang, Hongwei Sun

Connect to this object online.

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC by Pingyu Chen, Pingyu Chen, Xintian Wang, Shengwen Zhu, Hongchao Li, Hongchao Li, Mingjun Rui, Yingcheng Wang, Haikui Sun, Aixia Ma, Aixia Ma

Connect to this object online.